Cadenza Bio Announces Peer-Reviewed Study Showing Oral, Brain-Penetrant ERβ Ligands Drive Remyelination and Functional Recovery in MS Models

Published in Scientific Reports, a Nature Portfolio journal, the study details dual acting small molecules that restore myelin, modulate inflammation, and improve visual pathway function in preclinical MS models. OKLAHOMA CITY, Oct. 9, 2025 /PRNewswire/ -- Cadenza Bio, Inc. today...

Read More